Taking action against pain

To support healthcare professionals and patients in managing pain and related diseases, Grünenthal has launched a number of initiatives and grants.

CHANGE PAIN®

Change Pain is an initiative endorsed by the European Pain Federation (EFIC) and Grünenthal. It aims to understand the needs of pain patients and develop solutions to improve the management of pain. Since the initiative was launched in 12 European countries in 2009, a great number of tools have been developed to make physicians’ daily practice easier, and more than 65,000 healthcare professionals have been involved in educational activities, either by completing web-based learning modules or attending workshops across Europe.
... Visit the Change Pain website

EFIC-Grünenthal Grant (E-G-G)

Biennial grants from Grünenthal offer €200,000 every two years for the E-G-G. E-G-G is intended to support early-career scientists to carry out innovative clinical pain research in any member country of the European Pain Federation EFIC®. Individual research grants are worth up to € 40,000 per project for a duration of up to two years. Research grants are intended for clinical and human experimental pain research, including innovative educational initiatives aimed at improving diagnosis and treatment of pain. The decision on awarding grants is made independently by a sub-group of the Working group for grants and prizes of the EFIC®.
... Check out the latest E-G-G research projects

Societal Impact of Pain (SIP)

The 'Societal Impact of Pain' (SIP) platform is a multi-stakeholder partnership led by the European Pain Federation EFIC and Pain Alliance Europe (PAE), which aims to raise awareness of pain and change pain policies. The platform provides opportunities for discussion for health care professionals, pain advocacy groups, politicians, healthcare insurance providers, representatives of health authorities, regulators, and budget holders. The scientific framework of the SIP platform is under the responsibility of EFIC and the strategic direction of the project is defined by both partners. The pharmaceutical companies Grünenthal GmbH and Pfizer are the main sponsors of the Societal Impact of Pain (SIP) platform.
... Read more about SIP

Brain, Mind and Pain Grant

The Brain, Mind and Pain ‘Patient-Centred Innovation Grant’ (BMP Grant) is an initiative of Pain Alliance Europe to identify, stimulate and encourage patient-centric and scientifically robust innovation in the areas of chronic pain and neurological disorders. The grant objectives focus on: access to innovative treatments, prevention and self-management approaches, reducing stigma, and research to improve quality of life. The biennial BMP Grant, partly funded by Grünenthal, is awardedby a jury of patient representatives and is supported by scientific experts to ensure the winning projects address challenges faced by patients.
... Read more about BMP